Levi & Korsinsky is investigating the Board of Directors of Epicor Software Corporation (Nasdaq: EPIC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Apax Partners Holdings Ltd. via a tender offer under which Epicor Software shareholders will receive $12.50 per share in cash. The tender offer is scheduled to be launched by April 8, 2011 and expire at the later of two days after the go shop period, (the go-shop ends on May 4, 2011), or 20 days after the launch. The Company agreed to a termination fee of $40,000,000, which drops to $15,000,000 for a termination with a qualified go-shop bidder and if other conditions are met.
The investigation concerns whether the Epicor Software Board of Directors breached their fiduciary duties to Epicor Software stockholders by failing to adequately shop the Company before entering into this transaction. In particular, the median price target set by six analysts for Epicor Software stock is $13 per share and at least one analyst set a price target of $14 per share. Also, after the deal was announced, equities research analysts at Feltl & Co. downgraded shares of Epicor from a “buy” rating to a “hold” rating.
If you own common stock in Epicor Software and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.